| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42.0M | -1.5% | +67.6% |
| Cost of Revenue | $24.1M | -7.3% | +87.0% |
| R&D Expense | $22.8M | -11.5% | +16.9% |
| SG&A Expense | $24.3M | +33.5% | +43.0% |
| Operating Income | -$115.9M | -48.5% | -243.2% |
| Pre-tax Income | -$108.8M | -48.1% | -237.5% |
| Income Tax | $457K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $268.9M | +16.8% | +98.3% |
| Current Assets | $335.4M | +18.9% | +85.1% |
| Total Assets | $702.2M | +21.2% | +40.5% |
| Current Liabilities | $65.1M | +11.7% | -7.2% |
| Total Liabilities | $303.0M | +37.9% | +48.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$76.3M | — | — |
| Capital Expenditures | $526K | — | — |
| Investing Cash Flow | -$57.0M | — | — |
| Financing Cash Flow | $204.5M | — | — |
| Free Cash Flow | -$76.9M | — | — |
| -63.6% |
| +104.4% |
| Net Income | -$109.3M | -46.2% | -402.4% |
| EPS (Basic) | -$0.27 | -42.1% | -350.0% |
| EPS (Diluted) | -$0.27 | -42.1% | -350.0% |
| $399.2M |
| +11.0% |
| +34.9% |